Results

1–5 of 5 results for macular atrophy

Extensive Macular Atrophy With Pseudodrusen: Expansion of Clinical Features Using Multimodal Imaging
Luiz Henrique Lima, MD
Annual Meeting Talks
2024
Early Signs of Atrophy in AMD, Nascent GA (nGA) and the Difference Between nGA and iRORA
Robyn H Guymer, MB BS PhD FRANZCO
Updates from the Field
2023
Anti-VEGF Resistant Subretinal Fluid Associated With Reduced Risk of Macular Atrophy and Better Vision: Drug-Induced Choroidal New Vessel Homeostasis?
Marco A. Zarbin, MD, PhD
Annual Meeting Talks
2020
AMD Neovascular Expert Panel
Robert L. Avery, MD
Nizar S Abdelfattah, M.D.
Nancy M. Holekamp, MD, FASRS
Peter K. Kaiser, MD FASRS
Pravin U. Dugel, MD
Annual Meeting Talks
2016
Episode 9: Rate of Macular Atrophy in HARBOR Study with Dr. SriniVas Sadda
Keyvan Koushan, MD, FRCSC
Member Podcasts
2018